The efficacy of proteasome inhibition for myeloma is limited by therapeutic resistance, which may be mediated by activation of the autophagy pathway as an alternative mechanism of protein degradation. Preclinical studies demonstrate that autophagy inhibition with hydroxychloroquine augments the anti...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!